Drug profile · INN
daridorexant hydrochloride
QUVIVIQ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
daridorexant hydrochloride (QUVIVIQ) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN daridorexant hydrochloride
Brand QUVIVIQ
Route ORAL
Formulation TABLET
Frequently asked questions
What is daridorexant hydrochloride?
daridorexant hydrochloride (QUVIVIQ) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for daridorexant hydrochloride?
QUVIVIQ is a marketed brand name for daridorexant hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of daridorexant hydrochloride?
daridorexant hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.